Welch Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.1M | Buy |
15,064
+7,415
| +97% | +$7.58M | 0.62% | 39 |
|
|
2026
Q1 | $7.04M | Sell |
7,649
-37
| -0.5% | -$37.5K | 0.26% | 58 |
|
|
2025
Q4 | $8.26M | Buy |
7,686
+172
| +2% | +$164K | 0.32% | 53 |
|
|
2025
Q3 | $5.73M | Buy |
7,514
+1,004
| +15% | +$747K | 0.22% | 59 |
|
|
2025
Q2 | $5.07M | Buy |
6,510
+75
| +1% | +$58.3K | 0.21% | 59 |
|
|
2025
Q1 | $5.29M | Sell |
6,435
-65
| -1% | -$54.1K | 0.23% | 56 |
|
|
2024
Q4 | $5.03M | Sell |
6,500
-48
| -0.7% | -$39.7K | 0.23% | 59 |
|
|
2024
Q3 | $5.8M | Buy |
6,548
+209
| +3% | +$188K | 0.25% | 56 |
|
|
2024
Q2 | $5.74M | Buy |
6,339
+398
| +7% | +$318K | 0.28% | 53 |
|
|
2024
Q1 | $4.62M | Buy |
5,941
+642
| +12% | +$457K | 0.23% | 56 |
|
|
2023
Q4 | $3.09M | Sell |
5,299
-218
| -4% | -$127K | 0.17% | 62 |
|
|
2023
Q3 | $2.96M | Buy |
5,517
+48
| +0.9% | +$24.7K | 0.18% | 60 |
|
|
2023
Q2 | $2.56M | Sell |
5,469
-256
| -4% | -$107K | 0.15% | 60 |
|
|
2023
Q1 | $1.97M | Sell |
5,725
-144
| -2% | -$48.6K | 0.11% | 65 |
|
|
2022
Q4 | $2.15M | Buy |
5,869
+45
| +0.8% | +$16K | 0.12% | 68 |
|
|
2022
Q3 | $1.88M | Sell |
5,824
-610
| -9% | -$193K | 0.12% | 63 |
|
|
2022
Q2 | $2.09M | Hold |
6,434
| – | – | 0.13% | 63 |
|
|
2022
Q1 | $1.84M | Buy |
6,434
+490
| +8% | +$126K | 0.11% | 72 |
|
|
2021
Q4 | $1.64M | Sell |
5,944
-188
| -3% | -$47.7K | 0.1% | 75 |
|
|
2021
Q3 | $1.42M | Hold |
6,132
| – | – | 0.1% | 72 |
|
|
2021
Q2 | $1.41M | Hold |
6,132
| – | – | 0.1% | 71 |
|
|
2021
Q1 | $1.15M | Buy |
6,132
+851
| +16% | +$166K | 0.08% | 74 |
|
|
2020
Q4 | $892K | Buy |
5,281
+574
| +12% | +$85.7K | 0.07% | 76 |
|
|
2020
Q3 | $697K | Sell |
4,707
-100
| -2% | -$15.5K | 0.06% | 79 |
|
|
2020
Q2 | $789K | Buy |
4,807
+1,102
| +30% | +$169K | 0.07% | 69 |
|
|
2020
Q1 | $514K | Buy |
3,705
+1,560
| +73% | +$214K | 0.05% | 75 |
|
|
2019
Q4 | $282K | Buy |
2,145
+355
| +20% | +$41.1K | 0.03% | 105 |
|
|
2019
Q3 | $200K | Hold |
1,790
| – | – | 0.02% | 111 |
|
|
2019
Q2 | $198K | Sell |
1,790
-35
| -2% | -$4.12K | 0.02% | 108 |
|
|
2019
Q1 | $237K | Buy |
1,825
+670
| +58% | +$81.5K | 0.03% | 112 |
|
|
2018
Q4 | $134K | Buy |
1,155
+8
| +0.7% | +$894 | 0.02% | 126 |
|
|
2018
Q3 | $123 | Buy |
+1,147
| New | +$115K | 0.01% | 140 |
|
|
2013
Q3 | – | Sell |
-198,934
| Closed | -$9.77M | – | 127 |
|
|
2013
Q2 | $9.77M | Buy |
+198,934
| New | +$10.8M | 2.54% | 29 |
|
Other funds holding LLY
SC
ONB
GIM
Welch Group's LLY Position: Q2 2026 in Review
Welch Group increased its Eli Lilly (LLY) stake by 97% in Q2 2026, buying an estimated $7.58M and bringing the position to 15,064 shares worth $18.1M. The position accounts for 0.62% of the portfolio, ranked #39.
Welch Group first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. 1,928 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Welch Group held 15,064 shares of Eli Lilly worth $18.1M as of Q2 2026.
- Welch Group bought 7,415 Eli Lilly shares in Q2 2026, an estimated $7.58M.
- Eli Lilly made up 0.62% of Welch Group's portfolio in Q2 2026, its #39 holding.
- Welch Group first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
- 1,928 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.